Pharmacological Modulation of Hippocampal Activity in Psychosis 2

NCT04559529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia; Psychosis

Interventions

DRUG: Levetiracetam (LEV) 500 mg
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center